|
1
|
Dorantes-Heredia R, Ruiz-Morales JM and
Cano-Garcia F: Histopathological transformation to small-cell lung
carcinoma in non-small cell lung carcinoma tumors. Transl Lung
Cancer Res. 5:401–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Buttery R, Monaghan H, Salter DM and Sethi
T: Galectin-3: Differential expression between small-cell and
non-small-cell lung cancer. Histopathology. 44:339–344. 2010.
View Article : Google Scholar
|
|
3
|
Santillan AA, Camargo CA Jr and Colditz
GA: A meta-analysis of asthma and risk of lung cancer (United
States). Cancer Causes Control. 14:327–334. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qu YL, Liu J, Zhang LX, Wu CM, Chu AJ, Wen
BL, Ma C, Yan XY, Zhang X, Wang DM, et al: Asthma and the risk of
lung cancer: A meta-analysis. Oncotarget. 8:11614–11620. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stading R, Gastelum G, Chu C, Jiang W and
Moorthy B: Molecular mechanisms of pulmonary carcinogenesis by
polycyclic aromatic hydrocarbons (PAHs): Implications for human
lung cancer. Semin Cancer Biol. 76:3–16. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosenberger A, Bickeböller H, McCormack V,
Brenner DR, Duell EJ, Tjønneland A, Friis S, Muscat JE, Yang P,
Wichmann HE, et al: Asthma and lung cancer risk: A systematic
investigation by the international lung cancer consortium.
Carcinogenesis. 33:587–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang L, Sun YQ, Langhammer A, Brumpton
BM, Chen Y, Nilsen T, Leivseth L, Wahl SGF and Mai XM: Asthma and
asthma symptom control in relation to incidence of lung cancer in
the HUNT study. Sci Rep. 11:45392021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Denholm R, Schüz J, Straif K, Stücker I,
Jöckel KH, Brenner DR, De Matteis S, Boffetta P, Guida F, Brüske I,
et al: Is previous respiratory disease a risk factor for lung
cancer? Am J Respir Crit Care Med. 190:549–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garth J, Barnes J and Krick S: Targeting
cytokines as evolving treatment strategies in chronic inflammatory
airway diseases. Int J Mol Sci. 19:34022018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Toskala E and Kennedy DW: Asthma risk
factors. Int Forum Allergy Rhinol. 5:S11–S16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bjorksten B: Genetic and environmental
risk factors for the development of food allergy. Curr Opin Allergy
Clin Immunol. 5:249–253. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hunt LW, Frigas E, Butterfield JH, Kita H,
Blomgren J, Dunnette SL, Offord KP and Gleich GJ: Treatment of
asthma with nebulized lidocaine: A randomized, placebo-controlled
study. J Allergy Clin Immunol. 113:853–859. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu Y, Davis S, Stephens R, Meltzer PS and
Chen Y: GEOmetadb: Powerful alternative search engine for the Gene
Expression Omnibus. Bioinformatics. 24:2798–2800. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen S, Li F, Tang Y, Dong L, He Y, Deng Y
and Tao Z: MIR222HG attenuates macrophage M2 polarization and
allergic inflammation in allergic rhinitis by targeting the
miR146a-5p/TRAF6/NF-κB axis. Front Immunol. 14:11689202023.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Simonson MA, Mcqueen MB and Keller MC:
Plot generated using STRING 9.0 (Search Tool for the Retrieval of
Interacting Genes). 2014.
|
|
16
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Y, Shu D, Shen M, Wu Q, Peng Y, Liu L,
Tang Z, Gao S, Wang Y and Liu S: Development and validation of a
novel PPAR signaling pathway-related predictive model to predict
prognosis in breast cancer. J Immunol Res. 2022:94121192022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng Z, Yu J, Yang Z, Du K, Chen Y and
Zhou L: Investigation of M2 macrophage-related gene affecting
patients prognosis and drug sensitivity in non-small cell lung
cancer: Evidence from bioinformatic and experiments. Front Oncol.
12:10964492022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang W, Hong HJ and Chen YL:
Establishment of a gallbladder cancer-specific survival model to
predict prognosis in non-metastatic gallbladder cancer patients
after surgical resection. Dig Dis Sci. 63:2251–2258. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu ZH and Yang DL: High CENPM mRNA
expression and its prognostic significance in hepatocellular
carcinoma: A study based on data mining. Cancer Cell Int.
20:4062020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Q, Xia T, Qi C, Du J and Ye C: High
expression of S100A2 predicts poor prognosis in patients with
endometrial carcinoma. BMC Cancer. 22:772022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li B, Li T, Liu JS and Liu XS:
Computational deconvolution of tumor-infiltrating immune components
with bulk tumor gene expression data. Methods Mol Biol.
2120:249–262. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sistek D, Tschopp JM, Schindler C,
Brutsche M, Ackermann-Liebrich U, Perruchoud AP and Leuenberger P:
Clinical diagnosis of current asthma: Predictive value of
respiratory symptoms in the SAPALDIA study. Swiss study on air
pollution and lung diseases in adults. Eur Respir J. 17:214–219.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hom S and Pisano M: Reslizumab (Cinqair):
An interleukin-5 antagonist for severe asthma of the eosinophilic
phenotype. P T. 42:564–568. 2017.PubMed/NCBI
|
|
26
|
van der Vliet A, Janssen-Heininger YMW and
Anathy V: Oxidative stress in chronic lung disease: From
mitochondrial dysfunction to dysregulated redox signaling. Mol
Aspects Med. 63:59–69. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Henderson I, Caiazzo E, McSharry C, Guzik
TJ and Maffia P: Why do some asthma patients respond poorly to
glucocorticoid therapy? Pharmacol Res. 160:1051892020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barnes PJ: Efficacy of inhaled
corticosteroids in asthma. J Allergy Clin Immunol. 102:531–538.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Raissy HH, Kelly HW, Harkins M and Szefler
SJ: Inhaled corticosteroids in lung diseases. Am J Respir Crit Care
Med. 187:798–803. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miller LS: Toll-like receptors in skin.
Adv Dermatol. 24:71–87. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaisho T and Akira S: Toll-like receptor
function and signaling. J Allergy Clin Immunol. 117:979–987. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu X, Wang P, Zhang Y, Gao L, Zheng B, Xu
Y and Mo J: Toll-like receptor characterization correlates with
asthma and is predictive of diagnosis. DNA Cell Biol. 39:1313–1321.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pandey RC, Michel S, Tesse R, Binia A,
Schedel M, Liang L, Klopp N, Franke A, von Berg A, Bufe A, et al:
Genetic variation in the toll-like receptor signaling pathway is
associated with childhood asthma. J Allergy Clin Immunol.
131:602–605. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Poltorak A, He X, Smirnova I, Liu MY,
Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al:
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations
in Tlr4 gene. Science. 282:2085–2088. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gnad F, Baucom A, Mukhyala K, Manning G
and Zhang Z: Assessment of computational methods for predicting the
effects of missense mutations in human cancers. BMC Genomics.
14:1–13. 2013. View Article : Google Scholar
|
|
36
|
Pelham CJ, Pandya AN and Agrawal DK:
Triggering receptor expressed on myeloid cells receptor family
modulators: A patent review. Exp Opin Ther Pat. 24:1383–1395. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun H, Feng J and Tang L: Function of
TREM1 and TREM2 in liver-related diseases. Cells. 9:26262020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu Q, Johnson EM, Lam RK, Wang Q, Ye HB,
Wilson EN, Minhas PS, Liu L, Swarovski MS, Tran S, et al:
Peripheral TREM1 responses to brain and intestinal immunogens
amplify stroke severity. Nat Immunol. 20:1023–1034. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bernal-Martínez L, Gonçalves SM, de Andres
B, Cunha C, Jimenez IG, Lagrou K, Mellado E, Gaspar ML, Maertens
JA, Carvalho A and Alcazar-Fuoli L: TREM1 regulates antifungal
immune responses in invasive pulmonary aspergillosis. Virulence.
12:570–583. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen B, Zhou M, Zhang H, Wang C, Hu X,
Wang B and Wang E: TREM1/Dap12-based CAR-T cells show potent
antitumor activity. Immunotherapy. 11:1043–1055. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mlecnik B, Bindea G, Pagès F and Galon J:
Tumor immunosurveillance in human cancers. Cancer Metastasis Rev.
30:5–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ribas A: Adaptive immune resistance: How
cancer protects from immune attackadaptive immune resistance.
Cancer Discov. 5:915–919. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chan TA, Yarchoan M, Jaffee E, Swanton C,
Quezada SA, Stenzinger A and Peters S: Development of tumor
mutation burden as an immunotherapy biomarker: Utility for the
oncology clinic. Ann Oncol. 30:44–56. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Palucka AK and Coussens LM: The basis of
oncoimmunology. Cell. 164:1233–1247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Klempner SJ, Fabrizio D, Bane S, Reinhart
M, Peoples T, Ali SM, Sokol ES, Frampton G, Schrock AB, Anhorn R
and Reddy P: Tumor mutational burden as a predictive biomarker for
response to immune checkpoint inhibitors: A review of current
evidence. Oncologist. 25:e147–e159. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cheng X, Wang X, Nie K, Cheng L, Zhang Z,
Hu Y and Peng W: Systematic pan-cancer analysis identifies TREM2 as
an immunological and prognostic biomarker. Front Immunol.
12:6465232021. View Article : Google Scholar : PubMed/NCBI
|
